Skip to main content
NIH funding notice RFA-CA-16-015

U.S.-Russia Bilateral Collaborative Research Partnerships on Cancer (R21)

Closed on November 4, 2016.

Posted
August 4, 2016
Close date
November 4, 2016
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

10 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,339,322 in first-year total cost, median $133,510.

Most frequent study sections

  1. Special Emphasis Panel[ZCA1 RPRB-O (M2)]10

Most frequent institutions

  1. ARIZONA STATE UNIVERSITY-TEMPE CAMPUS1
  2. HARVARD MEDICAL SCHOOL1
  3. MASSACHUSETTS GENERAL HOSPITAL1
  4. RESEARCH INST OF FOX CHASE CAN CTR1
  5. ROSWELL PARK CANCER INSTITUTE CORP1
Competing awards under RFA-CA-16-015 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2017Single-cell analysis of tumor-microenvironment interactions in follicular lymphoma1R21CA220147-01KHARCHENKO, PETER VWU, CATHERINE JU-YINGHARVARD MEDICAL SCHOOL, MA$154,207ZCA1
2017Identification of Essential Areas of the Brain in Pre-Operative Brain Tumor Patients Using BOLD fMRI and Independent Physiological Parameters1R21CA220144-01HOLODNY, ANDREI IPECK, KYUNGSLOAN-KETTERING INST CAN RESEARCH, NY$152,213ZCA1
2017Mechanisms of PARP-1 interaction with chromatin1R21CA220151-01STUDITSKY, VASILY MRESEARCH INST OF FOX CHASE CAN CTR, PA$146,400ZCA1
2017Inhibition of MYC interactions with chromatin-remodeling factors as a novel anti-melanoma strategy1R21CA220096-01NIKIFOROV, MIKHAILROSWELL PARK CANCER INSTITUTE CORP, NY$139,280ZCA1
2017Magnetic Resonance Spectroscopy and Molecular Imaging of Metabolic Pathways in Cancer1R21CA220137-01CHEKMENEV, EDUARDVANDERBILT UNIVERSITY MEDICAL CENTER, TN$135,900ZCA1
2017Optical imaging guided resection and photodynamic therapy of glioma with targeted photoactivable agents1R21CA220143-01HASAN, TAYYABAMASSACHUSETTS GENERAL HOSPITAL, MA$131,120ZCA1
2017Role of myosin IC in prostate cancer metastasis1R21CA220155-01HOFMANN, WILMA A.STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY$127,600ZCA1
2017Immunosignatures to Distinguish Breast Cancer Subtypes and Cancer Recurrence1R21CA220150-01JOHNSTON, STEPHEN ALBERTARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ$123,600ZCA1
2017Targeted Magneto-Mechanic Nanotherapeutics for Cancer1R21CA220148-01KABANOV, ALEXANDER VUNIV OF NORTH CAROLINA CHAPEL HILL, NC$117,589ZCA1
2017Focal Therapy of Prostate Cancer using Non-Thermal Tumor Ablation with Focused Ultrasound1R21CA219793-01SCHADE, GEORGE RUNIVERSITY OF WASHINGTON, WA$111,413ZCA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-CA-16-015: U.S.-Russia Bilateral Collaborative Research Partnerships on Cancer (R21) | ScienceDex | ConductScience